SNT 5.00% 4.2¢ syntara limited

Ann: Pharmaxis Submits US New Drug Application fo, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,181 Posts.
    lightbulb Created with Sketch. 12
    re: Ann: Pharmaxis Submits US New Drug Applic... I hope you are right but if it is anything like ACL and their FDA application under the GIVE initiative (priority review 6 months) for generic fonda we could be waiting a while :)

    In support of PXS, I believe Bronchitol to be a much simpler molecule than fondaparinux.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
0.002(5.00%)
Mkt cap ! $57.67M
Open High Low Value Volume
4.0¢ 4.3¢ 4.0¢ $48.01K 1.160M

Buyers (Bids)

No. Vol. Price($)
3 1025000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 461843 2
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.